Glycogen synthase kinase-3: A potential target for diabetes

被引：19

作者：

Teli, Divya M. ^{[1
]}

Gajjar, Anuradha K. ^{[1
]}

机构：

[1] LM Coll Pharm, Dept Pharmaceut Chem & Qual Assurance, Ahmadabad 380009, Gujarat, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2023年 / 92卷

关键词：

Glycogen synthase kinase-3; Glycogen metabolism; Diabetes; Inhibitors; ALZHEIMERS-DISEASE; GSK-3; INHIBITORS; PROTEIN-KINASE; SUBSTRATE-SPECIFICITY; MOLECULAR-MECHANISM; TAU PHOSPHORYLATION; PEPTIDE INHIBITORS; STRUCTURAL BASIS; PHASE-II; INSULIN;

D O I：

10.1016/j.bmc.2023.117406

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Elevated circulating glucose level due to & beta;-cell dysfunction has been a key marker of Type-II diabetes. Glycogen synthase kinase-3 (GSK-3) has been recognized as an enzyme involved in the control of glycogen metabolism. Consequently, inhibitors of GSK-3 have been explored for anti-diabetic effects in vitro and in animal models. Further, the mechanisms governing the regulation of this enzyme have been elucidated by means of a combination of structural and cellular biological investigations. This review article examines the structural analysis of GSK-3 as well as molecular modeling reports from numerous researchers in the context of the design and development of GSK-3 inhibitors. This article centers on the signaling pathway of GSK-3 relevant to its potential as a target for diabetes and discusses advancements till date on different molecular modification approaches used by researchers in the development of novel GSK-3 inhibitors as potential therapeutics for the treatment of Type II diabetes.

引用

页数：19

共 50 条

[41] Deletion of Glycogen Synthase Kinase-3β in Cartilage Results in Up-Regulation of Glycogen Synthase Kinase-3α Protein Expression
Gillespie, J. R.
Ulici, V.
Dupuis, H.
Higgs, A.
DiMattia, A.
Patel, S.
Woodgett, J. R.
Beier, F.
ENDOCRINOLOGY, 2011, 152 (05) : 1755 - 1766
[42] Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes
Henriksen, Erik J.
Dokken, Betsy B.
CURRENT DRUG TARGETS, 2006, 7 (11) : 1435 - 1441
[43] Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
Eui-Man Jung
Jeffrey J.Moffat
Woo-Yang Kim
Neural Regeneration Research, 2015, 10 (12) : 1912 - 1913
[44] Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
Jung, Eui-Man
Moffat, Jeffrey J.
Kim, Woo-Yang
NEURAL REGENERATION RESEARCH, 2015, 10 (12) : 1912 - 1913
[45] Glycogen synthase kinase-3 - A new target for lithium's effects in bipolar patients?
Agam, G
Levine, J
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1998, 13 (07) : 463 - 465
[46] Controlling the cytokine storm by insulin:: Glycogen synthase kinase-3 as a target in systemic inflammation
Mühl, H
Pfeilschifter, J
CRITICAL CARE MEDICINE, 2006, 34 (05) : 1567 - 1569
[47] Inhibition of Glycogen Synthase Kinase-3: An Emerging Target in the Treatment of Traumatic Brain Injury
Shim, Seong S.
Stutzmann, Grace E.
JOURNAL OF NEUROTRAUMA, 2016, 33 (23) : 2065 - 2076
[48] Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
Maqbool, Mudasir
Mobashir, Mohammad
Hoda, Nasimul
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 107 : 63 - 81
[49] Blind docking of manzamines into glycogen synthase kinase-3β
Sivaprakasam, P.
Hamann, M.
Doerksen, R. J.
PLANTA MEDICA, 2008, 74 (03) : 335 - 335
[50] Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease
Huang, Hui-Chuan
Klein, Peter S.
CURRENT DRUG TARGETS, 2006, 7 (11) : 1389 - 1397

← 1 2 3 4 5 →